<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02337556</url>
  </required_header>
  <id_info>
    <org_study_id>13.23.CLI</org_study_id>
    <nct_id>NCT02337556</nct_id>
  </id_info>
  <brief_title>The DIVINE Study: DIetary Management of Glucose VarIability iN thE ICU</brief_title>
  <official_title>The DIVINE Study: DIetary Management of Glucose VarIability iN thE ICU</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nestlé</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nestlé</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the nutritional effect on blood glucose of two commercially available enteral
      diets in overweight or obese patients in the Intensive Care Unit.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 2014</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">October 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glucose variability - Number of glycemic events outside the serum glucose range of 110-150 mg/dl</measure>
    <time_frame>First seven days in the ICU</time_frame>
    <description>Number of glycemic events outside the serum glucose range of 110-150 mg/dl</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Glucose variability - Number of glycemic events between 80-110 mg/dl and 150-180 mg/dl</measure>
    <time_frame>First seven days in the ICU</time_frame>
    <description>Number of glycemic events between 80-110 mg/dl and 150-180 mg/dl</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glucose variability - Number of episodes of hypoglycemia (glucose &lt; 80 mg/dl)</measure>
    <time_frame>First seven days in the ICU</time_frame>
    <description>Number of episodes of hypoglycemia (glucose &lt; 80 mg/dl)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glucose variability - Number of episodes of hyperglycemia (glucose &gt; 180 mg/dl)</measure>
    <time_frame>First seven days in the ICU</time_frame>
    <description>Number of episodes of hyperglycemia (glucose &gt; 180 mg/dl)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glucose variability - Average glucose levels</measure>
    <time_frame>First seven days in the ICU</time_frame>
    <description>Average glucose levels</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for exogenous insulin administration</measure>
    <time_frame>First seven days in the ICU</time_frame>
    <description>Number of administrations, amount of insulin received, number of times insulin order adjusted, circulating C-peptide at baseline, day 3, 5 and 7</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for exogenous glucose administration</measure>
    <time_frame>First seven days in the ICU</time_frame>
    <description>Number of times of administration and amount of glucose received</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nursing time</measure>
    <time_frame>First seven days in the ICU</time_frame>
    <description>Time required to monitor glucose levels and adjust insulin regimens in subset of patients studied</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">106</enrollment>
  <condition>Critically Ill Mechanically Ventilated Subjects</condition>
  <arm_group>
    <arm_group_label>Intervention Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Peptamen Bariatric</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Replete</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Peptamen Bariatric</intervention_name>
    <description>Commercially available enteral diet</description>
    <arm_group_label>Intervention Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Replete</intervention_name>
    <description>Commercially available enteral diet</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  New admit to the ICU and expected to remain in ICU 5 days

          -  Ventilator dependent up to 48 hours prior to admission to the study

          -  Requiring tube feeding enteral nutrition (EN) 5 days

          -  Expected to receive 50% of caloric needs within 72 hours

          -  Body Mass Index 26-45

        Exclusion Criteria:

          -  Trauma patients

          -  Major surgery in past 30 days or planned for next 7 days

          -  Diabetes mellitus (DM) type 1

          -  Admitted with diagnosis of diabetic ketoacidosis as primary diagnosis

          -  Pregnant or lactating

          -  Non-functioning GI tract

          -  Use of parenteral nutrition in past 30 days

          -  Admitted with burns &gt; 20% body surface area

          -  Traumatic brain injury

          -  Hemodynamic instability that prevents delivery of EN &gt; 24hr

          -  Unable to access GI tract for feeding via tube, unable to receive EN

          -  Other contraindication to tube feeding

          -  Any other condition that would not allow patient to complete the study protocol

          -  Use of enteral formula at enrollment that cannot be changed to the investigational
             product
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Emory University Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Chicago Medicine</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Kentucky Albert B. Chandler Hospital</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40536</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Regions Hospital</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wake Forest University Health Sciences</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Queen's University</name>
      <address>
        <city>Kingston</city>
        <state>Ontario</state>
        <zip>K7L 2V7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 9, 2015</study_first_submitted>
  <study_first_submitted_qc>January 12, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 13, 2015</study_first_posted>
  <last_update_submitted>January 25, 2018</last_update_submitted>
  <last_update_submitted_qc>January 25, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

